DionyMed Brands Inc. Began Trading November 28 and Provides Operational Update

TORONTO–(BUSINESS WIRE)–DionyMed Brands Inc. (“DionyMed” or the “Company”) (formerly Sixonine
Ventures Corp.) (CSE: DYME), a multi-state cannabis brand and
distribution platform, is providing an operational update following the
commencement of trading of the Company’s shares on the Canadian
Securities Exchange on November 28, 2018.

Operational Highlights

  • On August 31, 2018, completed the acquisition of JDK Holdings LLC dba
    Winberry Farms, which is an award-winning concentrates and vape
    cartridge brand founded in Oregon;
  • Signed a binding term sheet to acquire a distribution license in the
    State of Nevada;
  • On October 31, 2018, completed an investment in HomeTown Heart, a
    direct-to-consumer non-retail storefront delivery dispensary. This
    investment includes the option, but not the obligation, for DionyMed
    to purchase the outstanding shares of HomeTown Heart on or before
    December 31, 2020;
  • The Company completed a reverse take-over (“RTO”) with DionyMed
    Holdings Inc. on November 27, 2018 and began trading on the Canadian
    Securities Exchange under the ticker “DYME” on November 29, 2018; and
  • Raised approximately C$35 million through a private placement offering
    in connection with the completion of its RTO.

Edward Fields, CEO of DionyMed, commented, “DionyMed has become a
leading player in the U.S. cannabis market due to our ability to offer
today’s premium cannabis brands through our distribution and
direct-to-consumer delivery platform. We are proving the strength of our
existing operational infrastructure, and the C$35m equity financing will
help further scale our operations and expand our operational footprint
across the U.S.”

He continued, “Capital efficiency is quickly becoming a key success
metric for cannabis operators. We are pleased to have successfully
reached a level of our growth where we are well capitalized to further
develop our vertically integrated platform. We are now focused on
expanding our premium cannabis brand portfolio, enhancing our
distribution reach and strengthening our manufacturing capabilities
through strategic acquisitions.”

In addition to the above, DionyMed also achieved the following:

  • On October 1, 2018, the Company acquired the assets of Cascade
    Distribution, Inc., enabling DionyMed to expand its distribution and
    processing capabilities in Oregon;
  • Launched Cali Chill, a direct-to-consumer e-commerce site; and
  • Launched Winberry Farms brand in California in November, 2018.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands and
distribution platform, supporting cultivators, manufacturers and
award-winning brands in the medical and adult-use cannabis markets.
DionyMed entered the cannabis industry in the vape cartridge
manufacturing category and following California’s adult-use legalization
in January 2018, expanded from manufacturing into distribution. DionyMed
sells branded products in every category from flower to vape cartridges,
concentrates and edibles. DionyMed serves more than 700 dispensaries and
completes over 40,000 Direct-To-Consumer deliveries each month with its
growing portfolio of products and brands.

Forward-Looking Information and Statements

This news release contains certain “forward-looking information” within
the meaning of applicable Canadian securities legislation and may also
contain statements that may constitute “forward-looking statements”
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only the Company’s beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of the Company’s control. Generally, such forward-looking
information or forward-looking statements can be identified by the use
of forward-looking terminology such as “plans”, “expects” or “does not
expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”,
“intends”, “anticipates” or “does not anticipate”, or “believes”, or
variations of such words and phrases or may contain statements that
certain actions, events or results “may”, “could”, “would”, “might” or
“will be taken”, “will continue”, “will occur” or “will be achieved” and
include, without limitation, statements related to the development of
the Company’s vertically integrated platform, enhancing the Company’s
distribution reach and strengthening the Company’s manufacturing
capabilities through strategic acquisitions.

Although the Company believes that the assumptions and factors used
in preparing, and the expectations contained in, the forward-looking
information and statements are reasonable, undue reliance should not be
placed on such information and statements, and no assurance or guarantee
can be given that such forward-looking information and statements will
prove to be accurate, as actual results and future events could differ
materially from those anticipated in such information and statements.
The forward-looking information and forward-looking statements contained
in this press release are made as of the date of this press release, and
the Company does not undertake to update any forward-looking information
and/or forward-looking statements that are contained or referenced
herein, except in accordance with applicable securities laws. All
subsequent written and oral forward- looking information and statements
attributable to the Company or persons acting on its behalf is expressly
qualified in its entirety by this notice.